GLGianpaolo Lucignani

Gianpaolo Lucignani

*This is an algorithmically generated author record based on publicly available information.

Gianpaolo Lucignani has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oxidative Stress and Semen Quality Among Night- and Day-Shift Workers: A Cross-Sectional Study

    by Luca Boeri, Federica Passarelli, Ludovico Maria Basadonna, Edoardo Sorba, Giorgio Graps, Fabio Ciamarra, Damiano Dagnino, Valentina Parolin, Marco Nizzardo, Gianpaolo Lucignani, et al.

    Introduction: Infertility affects 15% of couples, with oxidative stress recognized as a key contributor to male infertility. Night-shift work, through circadian disruption, may exacerbate oxidative imbalance and impair reproductive function. This study investigates the impact of night-shift work on oxidative stress and semen quality and evaluates the potential benefits of antioxidant supplementation in this context. Materials and Methods: We retrospectively analysed 96 white-European men aged 18–45, seeking fertility assessment at a single academic centre. Participants were classified as day or night workers based on their shift schedule, and all underwent standardised clinical, hormonal, and semen evaluations. Oxidative stress was assessed using the d-ROMs test. A subgroup of 40 patients (20 per group) treated for 3 months with antioxidant supplementation (Drolessano) to evaluate changes in oxidative stress and semen parameters was also considered. Statistical comparisons were performed using non-parametric tests and logistic regression analyses. Results: Night-shift workers exhibit significantly higher oxidative stress levels compared to day workers (median D-ROMs values of 340 vs. 280 U.CARR, p = 0.01), and a greater proportion of men exceeding the oxidative stress threshold (74.4% vs. 24.4%, p = 0.01). Logistic regression confirmed night-shift work as an independent predictor of elevated oxidative stress (OR 2.1, p = 0.001), even after adjusting for age and smoking. Following three months of antioxidant supplementation with Drolessano, both groups experienced significant reductions in oxidative stress (all p < 0.01), but night workers showed a substantially greater decrease (mean change −58.5 vs. −15.4 U.CARR, p = 0.001). Improvements in semen quality, including sperm concentration, motility, and morphology, were also more pronounced in the night group after treatment. Conclusions: At baseline, night-shift workers had significantly higher oxidative stress than day workers, likely due to circadian disruption. Both groups improved after antioxidant treatment, but night workers showed a greater reduction in D-ROMs. This pilot study might suggest a potential benefit of antioxidant therapy particularly in night workers.


  • Open Access

    Clinically Meaningful Improvements in Sperm DNA Fragmentation Severity in Infertile Men Treated with Superoxide Dismutase Supplementation: A Single-Center Experience

    by Luca Boeri, Gianpaolo Lucignani, Letizia Maria Ippolita Jannello, Matteo Turetti, Irene Fulgheri, Carlo Silvani, Franco Gadda, Paola Viganò, Edgardo Somigliana, Emanuele Montanari

    Background. Antioxidants are commonly used for the treatment of idiopathic male infertility. Previous studies have shown that antioxidants are able to improve sperm quality, but little is known about their impact on sperm DNA fragmentation (SDF). Preliminary findings showed that superoxide-dismutase (SOD)-based antioxidant plus hydroxytyrosol and carnosol (FertiPlus® SOD) therapy was associated with SDF improvement in a small cohort of infertile men. Therefore, we aimed to assess rates of and predictors of semen parameters and SDF improvements in infertile men treated with FertiPlus® SOD therapy (SOD+) or with other antioxidants without SOD (SOD−) in the real-life setting. Methods. Data from 60 consecutive infertile men with baseline SDF ≥ 30% and treated with SOD+ or SOD− for at least three months were analyzed. Clinical parameters and serum hormones were collected. Sperm parameters and SDF were requested at baseline and after SOD+ or SOD− treatment. Clinically meaningful SDF change after treatment was defined as SDF improvement >20% compared to baseline. Propensity score matching was performed to adjust for baseline differences between groups. Descriptive statistics were used to compare clinical and hormonal characteristics between SOD+ and SOD− groups. Semen characteristics were compared before and after treatment. Logistic regression models investigated the association between clinical variables and SDF improvement. Results. Groups were similar in terms of clinical, serum hormones and semen parameters at baseline after matching. Compared to baseline, sperm progressive motility (17 (10–36)% vs. 27 (12–41)%) and normal morphology (2 (1–6)% vs. 4 (2–6)%) significantly improved after SOD+ treatment (all p < 0.01), but not after SOD−. SDF values significantly improved after treatment in both groups, compared to the baseline evaluation (all p < 0.01). However, SDF values were lower after SOD+ than SOD− treatment (30 (22–36)% vs. 37 (31–42)%, p = 0.01). Similarly, a clinically meaningful improvement in SDF at follow-up was more frequently found after SOD+ than SOD− treatment (76.7% vs. 20.0%, p = 0.001). Multivariable logistic regression analysis showed that SOD+ treatment (OR 5.4, p < 0.001) was an independent predictor of clinically meaningful SDF improvement, after accounting for age and baseline FSH values. Conclusions. This cross-sectional study showed that, in a cohort of primary infertile men with SDF ≥ 30%, SOD-based treatment was significantly effective in improving SDF compared to antioxidants without SOD. Approximately 80% of men treated with SOD+ achieved clinically meaningful improvement in SDF after three months of treatment. Sperm progressive motility and normal morphology also improved after SOD+ therapy but not after SOD−. These results suggest that SOD+ treatment could be considered an effective option for the management of idiopathic infertile men with elevated SDF.


  • Open Access

    Coenzyme Q10 and Melatonin for the Treatment of Male Infertility: A Narrative Review

    by Gianpaolo Lucignani, Letizia Maria Ippolita Jannello, Irene Fulgheri, Carlo Silvani, Matteo Turetti, Franco Gadda, Paola Viganò, Edgardo Somigliana, Emanuele Montanari, Luca Boeri

    Background: Lifestyle and environmental factors can negatively impact fertility by means of oxidative stress. In this context, antioxidant supplementation therapy has gained much interest in recent years, and different molecules, alone or in combination, have been studied. Objective: The purpose of the present review is to investigate the evidence regarding the efficacy of coenzyme Q10 (CoQ10) and melatonin on male infertility. Methods: A literature search using PUBMED database from 2000 to October 2022 was performed to explore the role of CoQ10 and melatonin on male reproductive function. Conclusions: The analysis involved a narrative synthesis. CoQ10, alone or in combination, appears to reduce testicular oxidative stress and sperm DNA fragmentation and to improve sperm parameters; particularly sperm motility. Moreover, CoQ10 treatment is associated with higher pregnancy rates, both naturally and through assisted reproductive technology (ART). Larger studies are needed to precisely determine its clinical efficacy. Melatonin is a known antioxidant and preclinical studies have shown its ability to modulate reproductive function through hormonal and immune system regulation and sperm cell proliferation. Regardless, clinical studies are necessary to assess its potential in male infertility.